|Epigentek Releases Kits for Complete and Systematic Detection of All Histone H3 Modification Patterns
|NEW YORK, Jan 5 - Epigentek Group Inc. announced today that it released 24 commercial assay kits for detecting histone methylation patterns including mono-, di-, and tri- methylation changes at H3-K4, H3-K9, H3-K27 (http://www.epigentek.com/catalog/histone-methylation-quantification-c-23_52.html).
These kits use a proprietary and unique procedure/composition to quantify the histone H3 modification colorimetrically or fluorometrically and would provide powerful tools for detecting histone H3 modification patterns at all sites and degrees separately or simultaneously.
An additional 40 kits will be also released for detection of other histone H3 modification patterns including methylation, acetylation, and phosphorylation later this month.
About Epigentek Group Inc.
Epigentek Group Inc. is a biotechnology company that focuses on developing and providing innovative technology and products as a complete and systematic solution for epigenetics-related research and drug discovery. The company has developed a comprehensive portfolio of more than 400 proprietary products that are used all around the world by esteemed academia, leading pharmaceuticals, and cutting edge biotechnology companies. These unique products are specifically designed to make assays significantly more simple, fast, convenient and efficient than conventional methods. The company, particularly emphasizing speed and effectiveness in its technologies, continues to focus on epigenetic innovation and to extensively develop and enhance its product portfolio. Visit our website at www.epigentek.com.